Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orthofix Medical (OFIX) Depreciation & Amortization (CF) (2016 - 2025)

Orthofix Medical's Depreciation & Amortization (CF) history spans 15 years, with the latest figure at $13.1 million for Q4 2025.

  • For the quarter ending Q4 2025, Depreciation & Amortization (CF) fell 18.23% year-over-year to $13.1 million, compared with a TTM value of $77.3 million through Dec 2025, up 28.74%, and an annual FY2025 reading of $77.3 million, up 28.74% over the prior year.
  • Depreciation & Amortization (CF) for Q4 2025 was $13.1 million at Orthofix Medical, up from $12.9 million in the prior quarter.
  • The five-year high for Depreciation & Amortization (CF) was $34.4 million in Q1 2025, with the low at $6.5 million in Q2 2022.
  • Average Depreciation & Amortization (CF) over 5 years is $12.5 million, with a median of $13.0 million recorded in 2025.
  • Year-over-year, Depreciation & Amortization (CF) fell 20.81% in 2021 and then surged 131.67% in 2025.
  • Tracing OFIX's Depreciation & Amortization (CF) over 5 years: stood at $7.4 million in 2021, then fell by 0.34% to $7.4 million in 2022, then surged by 88.24% to $14.0 million in 2023, then grew by 14.5% to $16.0 million in 2024, then dropped by 18.23% to $13.1 million in 2025.
  • Per Business Quant, the three most recent readings for OFIX's Depreciation & Amortization (CF) are $13.1 million (Q4 2025), $12.9 million (Q3 2025), and $16.9 million (Q2 2025).